NEXGEL, INC. Payments to Acquire Productive Assets
NEXGEL, INC. (NXGL) reported Payments to Acquire Productive Assets of $9.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2026-05-14
- NEXGEL, INC. payments to acquire productive assets for the quarter ending 2026-03-31 was $9.00K.
- NEXGEL, INC. payments to acquire productive assets for the quarter ending 2025-09-30 was $8.00K, a 38.46% decline year-over-year.
- NEXGEL, INC. payments to acquire productive assets for the quarter ending 2024-09-30 was $13.00K, a 96.37% decline year-over-year.
- NEXGEL, INC. payments to acquire productive assets for the quarter ending 2024-06-30 was $209.00K, a 26.67% increase year-over-year.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 9 month |
|---|---|---|---|
| 2026-03-31 | $9.00K 10-Q · filed 2026-05-14 | ||
| 2025-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $28.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $20.00K 10-Q · filed 2025-08-12 | ||
| 2024-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $222.00K derived: sum of 2 quarters · filed 2025-11-12 | $374.00K 10-Q · filed 2025-11-12 |
| 2024-06-30 | $209.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $361.00K 10-Q · filed 2025-08-12 | |
| 2024-03-31 | $152.00K 10-Q · filed 2025-05-13 | ||
| 2023-09-30 | $358.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $523.00K derived: sum of 2 quarters · filed 2024-11-13 | $611.00K 10-Q · filed 2024-11-13 |
| 2023-06-30 | $165.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $253.00K 10-Q · filed 2024-08-19 | |
| 2023-03-31 | $88.00K 10-Q · filed 2024-05-13 | ||
| 2022-09-30 | $57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $88.00K derived: sum of 2 quarters · filed 2023-11-13 | $88.00K 10-Q · filed 2023-11-13 |
| 2022-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $31.00K 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 | ||
| 2021-09-30 | $123.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $123.00K derived: sum of 2 quarters · filed 2022-11-08 | $390.00K 10-Q · filed 2022-11-08 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $267.00K 10-Q · filed 2022-08-10 | |
| 2021-03-31 | $267.00K 10-Q · filed 2022-05-13 | ||
| 2020-09-30 | $76.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $151.00K derived: sum of 2 quarters · filed 2021-11-10 | $152.00K 10-Q · filed 2021-11-10 |
| 2020-06-30 | $75.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $76.00K 10-Q · filed 2021-08-16 | |
| 2020-03-31 | $1.00K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |